Glaukos (GKOS) Gross Profit (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,827.88% |
| Dec 31, 2025 | -101.45% |
| Sep 30, 2025 | 7.70% |
| Jun 30, 2025 | 18.06% |
| Mar 31, 2025 | 7.13% |
| Dec 31, 2024 | 3.75% |
| Sep 30, 2024 | 1.29% |
| Jun 30, 2024 | 11.90% |
| Mar 31, 2024 | 2.98% |
| Dec 31, 2023 | 6.61% |
| Sep 30, 2023 | -1.26% |
| Jun 30, 2023 | 8.00% |
| Mar 31, 2023 | 3.38% |
| Dec 31, 2022 | -0.74% |
| Sep 30, 2022 | -0.81% |
| Jun 30, 2022 | 8.36% |
| Mar 31, 2022 | -10.21% |
| Dec 31, 2021 | -5.00% |
| Sep 30, 2021 | -1.65% |
| Jun 30, 2021 | 17.53% |
| Mar 31, 2021 | -4.30% |
| Dec 31, 2020 | 14.38% |
| Sep 30, 2020 | 374.21% |
| Jun 30, 2020 | -56.64% |
| Mar 31, 2020 | -54.34% |
| Dec 31, 2019 | -1.69% |
| Sep 30, 2019 | 0.15% |
| Jun 30, 2019 | 8.13% |
| Mar 31, 2019 | -0.09% |
| Dec 31, 2018 | 23.91% |
| Sep 30, 2018 | 2.42% |
| Jun 30, 2018 | 7.73% |
| Mar 31, 2018 | -7.22% |
| Dec 31, 2017 | 6.70% |
| Sep 30, 2017 | -2.99% |
| Jun 30, 2017 | 16.39% |
| Mar 31, 2017 | 8.34% |
| Dec 31, 2016 | 10.39% |
| Sep 30, 2016 | 6.17% |
| Jun 30, 2016 | 21.16% |
| Mar 31, 2016 | 19.72% |
| Dec 31, 2015 | 6.36% |
| Sep 30, 2015 | 8.37% |
| Jun 30, 2015 | 21.91% |
| Mar 31, 2015 | 28.71% |
| Dec 31, 2014 | -6.64% |
| Sep 30, 2014 | 12.79% |
| Jun 30, 2014 | 38.94% |